Vendidas unas pocas FGEN a $49.72 y unas AMRN a $7.62.
announced that it is offering shares of its common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. In addition, Catalyst expects to grant the underwriters of the offering a 30-day option to purchase up to an additional 15% of the number of shares of common stock offered in the public offering at the public offering price less the underwriting discounts and commissions. All of the shares in the offering are being offered by Catalyst.
2 días actualizado, sigue fuera de bollinguer tanto en 2 días como un día.
Tiene/debe corregir algo.
off2- encontré ee gráfico por twitter, ... me alude pues estoy en algunas..
Parece que su caída en after se deba a Pharmamar. Después de los resultados de Microsoft ha recuperado
Resultados, el jueves 4.
New COVID-19 therapy co uld be ‘30 times more potent than Remdesivirhttps://www.msn.com/en-us/health/medical/new-covid-19-therapy-could-be-e2-80-9830-times-more-potent-than-remdesivir-e2-80-99/ar-BB1d55tw?ocid=uxbndlbing
A 5,75 la ponen
public offering of 8,700,000 shares of its common stock, offered at a price of $5.75 per share to the public. Additionally, the Company has granted the underwriters a 30-day option to purchase up to an additional 1,305,000 shares of its common stock. All of the shares in the offering are being offered by the Company. The offering is expected to close on or about January 29, 2021